Compare GBIO & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GBIO | FSP |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 100.4M |
| IPO Year | 2020 | N/A |
| Metric | GBIO | FSP |
|---|---|---|
| Price | $5.77 | $0.93 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.88 | N/A |
| AVG Volume (30 Days) | 65.6K | ★ 474.4K |
| Earning Date | 11-05-2025 | 02-10-2026 |
| Dividend Yield | N/A | ★ 4.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,270,000.00 | ★ $109,497,000.00 |
| Revenue This Year | N/A | $4.36 |
| Revenue Next Year | N/A | $0.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.00 | $0.85 |
| 52 Week High | $12.40 | $2.09 |
| Indicator | GBIO | FSP |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 45.00 |
| Support Level | $5.40 | $0.85 |
| Resistance Level | $5.69 | $0.95 |
| Average True Range (ATR) | 0.22 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 87.72 | 57.42 |
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.